KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
KPRX on Nasdaq
Shares outstanding
3,938,449
Price per share
$2.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
706,945
Total reported value
$1,392,679
% of total 13F portfolios
0%
Share change
+90,776
Value change
+$165,896
Number of holders
19
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% $1,095,537 365,179 ADAR1 Capital Management GP, LLC 30 Jun 2025
Nantahala Capital Management, LLC 10% 0% $1,018,394 +$160,860 363,712 +19% Nantahala Capital Management, LLC 30 Sep 2025
HIRSCHMAN ORIN 4.9% -40% $380,178 -$123,265 192,984 -24% Orin Hirschman 31 Dec 2025
Nantahala Capital Partners Limited Partnership 5.3% $569,115 189,705 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 08 Aug 2025
Alyeska Investment Group, L.P. 2.5% $249,572 75,628 Alyeska Investment Group, L.P. 31 Dec 2024
GOLDMAN SACHS GROUP INC 0% $429 130 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024

As of 31 Dec 2025, 19 institutional investors reported holding 706,945 shares of KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX). This represents 18% of the company’s total 3,938,449 outstanding shares.

Top 21 Institutional Shareholders

The largest institutional shareholders of KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) together control 18% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ADAR1 Capital Management, LLC 4.3% 167,941 0% 0.02% $330,844
Stonepine Capital Management, LLC 3.3% 131,144 -6.7% 0.21% $258,354
DRW Securities, LLC 2.8% 110,282 +199% 0.02% $217,255
Nantahala Capital Management, LLC 2.7% 106,156 -32% 0.01% $209,127
Alyeska Investment Group, L.P. 2% 76,904 0% $151,501
VANGUARD GROUP INC 0.84% 33,091 +58% 0% $65,189
CITADEL ADVISORS LLC 0.57% 22,381 -50% 0% $44,091
GEODE CAPITAL MANAGEMENT, LLC 0.56% 22,010 +17% 0% $43,359
RENAISSANCE TECHNOLOGIES LLC 0.54% 21,200 +71% 0% $41,764
XTX Topco Ltd 0.3% 11,971 0% $23,583
Tower Research Capital LLC (TRC) 0.04% 1,584 0% $3,120
MILLER WEALTH ADVISORS, LLC 0.03% 1,000 0% $1,970
UBS Group AG 0.02% 912 -33% 0% $1,797
SBI Securities Co., Ltd. 0.01% 256 0% 0% $504
BlackRock, Inc. 0% 58 0% 0% $114
BANK OF AMERICA CORP /DE/ 0% 29 +16% 0% $57
NewEdge Advisors, LLC 0% 22 0% 0% $43
OSAIC HOLDINGS, INC. 0% 2 0% 0% $3
Activest Wealth Management 0% 2 0% 0% $4
TWO SIGMA INVESTMENTS, LP 0% 0 -100% $0
CITIGROUP INC 0% 0 -100% $0

Institutional Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (KPRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 706,945 $1,392,679 +$165,896 $1.97 19
2025 Q3 616,169 $1,714,712 -$910,084 $2.78 17
2025 Q2 931,843 $2,683,707 -$1,054,952 $2.88 16
2025 Q1 1,285,403 $3,869,063 +$78,079 $3.01 18
2024 Q4 1,259,459 $4,164,082 +$76,847 $3.30 16
2024 Q3 1,213,569 $4,441,661 +$905,961 $3.66 18
2024 Q2 966,044 $4,057,360 +$4,057,360 $4.20 15